Dermatology · Southampton, PA
NPI
1134488638
Since 2012
Specialty
Dermatology
Code 207N00000X
Group practices
3
Medicare group memberships
Hospitals
1
Hospital affiliations
1122 Street Rd Ste 204
Southampton, PA, 18966
Phone (215) 999-7546
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.8M
53,838 services
Medicare patients, 2024
1,657
Average age 77
Drug cost, 2024
$1.6M
8,838 prescriptions
Company payments, 2025
$7,318
From 26 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Roman Bronfenbrener was code J7345 (aminolevulinic acid hcl for topical administration, 10% gel, 10 mg), 28,500 times for 127 patients. In total Roman Bronfenbrener billed 53,838 services in 130 codes, and Medicare paid $1.8M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-04-05.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J7345 Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | Office | 28,500 | 127 | $1.32 | $38K |
| 17003 Destruction Skin Lesion | Office | 8,952 | 976 | $5.41 | $48K |
| 17000 Destruction Skin Lesion | Office | 2,061 | 1,126 | $33.10 | $68K |
| 99214 Office E&M - Established | Office | 1,400 | 894 | $95.07 | $133K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 1,380 | 228 | $0.76 | $1,046 |
| 99213 Office E&M - Established | Office | 1,247 | 824 | $67.74 | $84K |
| 88331 Surgical Pathology Examination | Office | 560 | 348 | $76.02 | $43K |
| 17110 Destruction Skin Lesion | Office | 352 | 312 | $72.13 | $25K |
| 11301 Removal or Shaving of Skin Growth | Office | 347 | 292 | $73.56 | $26K |
| 11102 Skin Biopsy | Office | 335 | 313 | $59.65 | $20K |
| 11311 Removal or Shaving of Skin Growth | Office | 332 | 286 | $89.45 | $30K |
| 11302 Removal or Shaving of Skin Growth | Office | 285 | 243 | $95.80 | $27K |
| 99204 Office E&M - New | Office | 275 | 275 | $114.14 | $31K |
| 17311 Mohs Surgery | Office | 267 | 235 | $408.07 | $109K |
| 17004 Destruction Skin Lesion | Office | 265 | 214 | $133.15 | $35K |
By year: 2022 $1.1M for 44,413 services; 2023 $1.5M for 59,829 services; 2024 $1.8M for 53,838 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88331 Surgical Pathology Examination | 560 | 348 | $76.02 | $43K |
Medicare prescription drug claims, 2024
In 2024, the drug Roman Bronfenbrener prescribed most often to Medicare patients was Ketoconazole, with 3,057 prescriptions and refills. In total Roman Bronfenbrener wrote 8,838 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ketoconazole Generic | 3,057 | 3,165 | 656 | $52K |
| Betamethasone Dipropionate Generic | 714 | 760 | 258 | $33K |
| Triamcinolone Acetonide Generic | 660 | 700 | 303 | $8,206 |
| Fluocinonide Generic | 634 | 684 | 200 | $26K |
| Nystatin Generic | 349 | 373 | 91 | $7,187 |
| Ammonium Lactate Generic | 331 | 355 | 106 | $5,320 |
| Metronidazole Generic | 303 | 321 | 72 | $22K |
| Minoxidil Generic | 218 | 336 | 51 | $1,180 |
| Dupixent Pen Dupilumab | 201 | 205 | 26 | $770K |
| Doxycycline Hyclate Generic | 187 | 236 | 40 | $2,994 |
| Fluconazole Generic | 176 | 324 | 65 | $3,285 |
| Nyamyc Nystatin | 155 | 166 | 48 | $3,930 |
| Hydrocortisone Generic | 111 | 125 | 52 | $918 |
| Tacrolimus Generic | 107 | 108 | 34 | $15K |
| Ciclopirox Generic | 98 | 98 | 29 | $2,759 |
Brand drugs: 636 claims; generic drugs: 8,202 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Roman Bronfenbrener $7,318 ($7,318 in general payments such as food, travel and fees) from 26 companies. The largest payer was Abbvie Inc. with $1,059.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 69 | $1,059 |
| Janssen Biotech, Inc. JNJ | 53 | $875 |
| Mayne Pharma Commercial LLC | 35 | $735 |
| Galderma Laboratories, L.P. GALD.SW | 24 | $574 |
| Organon LLC OGN | 23 | $532 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 19 | $471 |
| Arcutis Biotherapeutics, Inc. ARQT | 14 | $353 |
| Incyte Corporation INCY | 20 | $314 |
| UCB, Inc. UCB.BR | 12 | $306 |
| Novartis Pharmaceuticals Corporation NVS | 17 | $294 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.